Article

Reckitt Recalls Painkiller after Finding Schizophrenia Drug Inside Package

Author(s):

Prescription-only Seroquel found in over-the-counter Nurofen packages leading to recall.

, a British consumer products group, has recalled its over-the-counter painkiller Nurofen Plus after discovering some packages contained a prescription-only, anti-psychotic used to treat severe psychiatric disorders, including schizophrenia.

"Reckitt Benckiser Ltd is now recalling all remaining unexpired stock of Nurofen Plus tablets in any pack size as a precautionary measure," reported the Medicines and Healthcare products Regulatory Agency (MHRA) in a safety alert issued Friday.

In the alert, the MHRA said that some consumers found 50mg tablets of the schizophrenia drug Seroquel instead of Nurofen. There were other consumers who found their packages contained strips of 100mg capsules of the anti-epileptic drug (AED), Neurontin.

An initial safety alert was issued on last Thursday after receiving reports that Seroquel tablets had been found in three separate batches of Nurofen.

According to the safety alert, consumers who mistakenly took Seroquel should be okay, as medical experts believe a single dose is not likely to cause significant issues for a healthy adult.

Ian Holloway from the MHRA's Defective Medicines Report Centre (DMRC) urged recent purchasers of Nurofen to “return them to your nearest pharmacy.”

Related Videos
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.